Pre-tax profits at Merck fall 26%

Pre-tax profits at an Irish arm of pharmaceutical giant, Merck last year decreased by 26% to €141m, new figures show.

Accounts filed by Organon (Ireland) Ltd show that pre-tax profits dropped by €50m from €191m after revenues decreased by 2.6% from €813.8m to €792.6m in the 12 months to the end of December last.

Numbers employed by the Dublin-based firm last year increased by 70 to 591 with the firm’s staff costs totalling €38.9m.